- Article
The Prognostic Value of Biomarkers Identified by [18F]FDG-PET/CT in Patients with High-Risk Melanoma Treated with Adjuvant Immunotherapy
- Anne-Line Mayland Madsen,
- Oke Gerke,
- Christina H. Ruhlmann,
- Malene Grubbe Hildebrandt and
- Sambavy Nadaraja
Background: Adjuvant anti-PD-1 therapy improves recurrence-free survival (RFS) in high-risk melanoma, but many patients experience adverse events. 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography with computed tomography [18F]FDG-PET/CT h...